Background {#Sec1}
==========

Infective endocarditis is a lethal disease caused by various pathogens such as bacteria, fungi, and rickettsia that directly invade the cardiac valves or mural endocardium \[[@CR1]\]. The profile of IE has been changing significantly over the past decades \[[@CR2]\]. Overall, IE related to rheumatic diseases has dramatically decreased in developed countries, being gradually replaced by IE associated with congenital heart disease, degenerative heart valve disease, prosthetic valves and cardiac implantable electronic devices \[[@CR3]\]. Staphylococci, which are most often related to healthcare and invasive procedures, have overtaken streptococci as the most common pathogen of IE \[[@CR4]\]. The average age of patients has also been increasing \[[@CR5]\]. In contrast, rheumatic disease remains a key predisposing factor in developing countries, and streptococci are still the most common cause of IE. In countries with reduced IVDU, right heart IE has also decreased; but in some regions such as eastern Europe, IVDU remains a problem and right-sided IE continues to occur \[[@CR6]\]. Many developed countries have a wealth of prospective or retrospective studies for IE \[[@CR7]--[@CR9]\]. However, there have been few studies of IE in China compared to other countries \[[@CR10]\]. To better profile the features of IE and the changes in clinical characteristics at Nanfang Hospital, a tertiary hospital in southern China, and find out the independent predictors of in-hospital mortality, we collected and analyzed the data from consecutive 313 cases of IE over a period of 18 year.

Methods {#Sec2}
=======

Diagnostic criteria {#Sec3}
-------------------

The definition of cases was based on the European Society of Cardiology (ESC) algorithm for diagnosis of infective endocarditis (2015 edition) \[[@CR11]\], which mainly includes the pathological diagnostic criteria and the modified Duke criteria.

Pathological examination served as the gold standard for diagnosing IE, which must meet at least one of the following criteria: microorganisms demonstrated by culture or on histological examination of a vegetation, a vegetation that has embolized, or an intracardiac abscess specimen or the presence of pathological lesions, vegetation or intracardiac abscesses by histological examination showing active endocarditis.

The modified Duke criteria (adapted from Li et al. \[[@CR12]\]) were used for clinical diagnosis with cases classified as either definite or suspected. For a diagnosis of definite IE, the patient must meet two major criteria, or one major criterion and three minor criteria, or five minor criteria. For a diagnosis of suspected IE, the patient must meet one major criterion and one minor criterion or three minor criteria. Major criteria include: (1) blood cultures positive for typical microorganisms consistent with IE from two separate blood cultures, microorganisms consistent with IE from persistently positive blood cultures; (2) imaging positive for IE by transthoracic echocardiogram; and (3) definite paravalvular lesions by cardiac CT. Minor criteria include: (1) predisposing heart condition or injection drug use; (2) fever of \> 38 °C; (3) vascular phenomena including those detected by imaging only, major arterial emboli, septic pulmonary infarcts, infectious mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, and Janeway's lesions; (4) immunological phenomena, glomerulonephritis, Osler's nodes, Roth's spots, or rheumatoid factor; (5) microbiological evidence, positive blood culture, but does not meet a major criterion as noted above or serological evidence of active infection with organisms consistent with IE. To exclude misdiagnosed cases as sepsis, non-infective endocarditis and rheumatic myocarditis, suspected patients should either show intracardiac vegetations by echocardiography with an evidence of bacterial infection, or meet the pathological diagnostic criteria.

Health care-associated IE was considered likely if any of the following had occurred: the patient had received intravenous therapy at home, received wound care or specialized nursing care through a health care agency, family, or friends, self-administered intravenous medical therapy in the past 30days, was examined at a hospital or hemodialysis clinic or received intravenous chemotherapy in the past 30 days, was hospitalized in an acute care hospital for two or more days in the previous 90 days before the infection, or resided in a nursing home or long-term care facility \[[@CR13]\].

Early surgery was defined as surgery within 20 days after diagnosis of IE \[[@CR14]\]. On the contrary, late surgery was defined as surgical intervention beyond 20 days after diagnosis.

In-hospital mortality was defined as death from any cause during hospitalization.

Study sample {#Sec4}
------------

Nanfang Hospital of Southern Medical University is a large tertiary teaching comprehensive hospital at Guangdong province in southern China with in-patient quantity up to 119,000 statistically in 2018, where surgery quantity in cardiothoracic surgery surpasses 1000 per year. We consecutively collected 313 inpatients diagnosed with IE through the electronic medical records system of Nanfang Hospital between June 2001 and June 2018. They were divided into two groups according to their time of admission: early-period group, from June 2001 to December 2009, and later-period group, from January 2010 to July 2018.

This clinical study was a retrospective and descriptive study consistent with the principles of the Helsinki declaration.

Data included demographic information, predisposing factors, clinical manifestations, laboratory tests including blood work and biochemical measurements, echocardiography results, causative microorganisms, pathologic findings and therapeutic outcomes. The outcomes included improvement at discharge of clinical symptoms, normal laboratory indicators, negative blood cultures and echocardiograms and worsening at discharge with abandonment of treatment because of poor efficacy or death.

Statistical method {#Sec5}
------------------

All analyses were performed using SPSS version 25.0.0. Continuous variables fitting a normal distribution were expressed as mean ± standard deviation. Categorical variables were expressed as frequency and percentage. Univariate comparisons were evaluated with the use of the independent sample *t* test for continuous variables, and Chi-squared tests or Fisher's exact test for categorical variables, if appropriate. Variables with theoretical clinical importance and those that achieved a *P* value of \< 0.10 in the univariate analysis were included in the binary logistic regression analysis. A forward conditional method was used to select the most useful predictors of the in-hospital mortality. A value of *P* \<  0.05 was considered significant.

Results {#Sec6}
=======

Basic information {#Sec7}
-----------------

A total of 313 IE patients were consecutively collected in this study, with 97 patients enrolled in the early-period group and 216 patients in the later-period group. Table [1](#Tab1){ref-type="table"} shows the basic information of the 313 patients. The later-period group was on average older (44.9 ± 15.4 yrs. vs 36.5 ± 15.2 yrs., *P* \<  0.001, 4.692--12.064), mainly due to more patients aged 41--60 years old (43.1% vs. 23.7%, OR = 2.433, CI: 1.418--4.174), and fewer patients aged 21--40 (35.2% vs. 56.7%, OR = 0.415, CI: 0.254--0.676). Each group had a similar male-female ratio, approximately 2.6:1 (72.2%). The top five departments that IE patients were initially admitted were cardiology (28.4%), cardiothoracic surgery (25.6%), infectious disease (15.0%), respiratory (7.7%), and nephrology (5.1%). The proportion of patients in the respiratory department declined in the later-period group (4.6% vs 14.4%, OR = 0.288, CI: 0.123--0.674). Regarding the factors predisposing to IE, 21 cases (6.7%) were considered as healthcare-associated IE. Basic heart diseases were the dominant predisposing factors (45.4%), including rheumatic heart disease (19.2%), congenital heart disease (16.6%) and degenerative heart valve disease (7.7%). IVDUs in the later-period group sharply decreased compared to the early-period group (12.0% vs 25.8%, OR = 0.394, CI: 0.214--0.727). The proportion of diabetic patients was higher in the later-period group, but without statistical significance (10.6% vs. 5.2%). Table 1Patient characteristicsVariableTotalEarly-period GroupLater-period GroupOR95% CI*PN* = 313*N* = 97*N* = 216LowerUpperAge (year)42.3 ±15.836.5 ± 15.244.9 ± 15.4−4.692−12.064\<  0.001\*  ≤ 2018 (5.8 )9 (9.3)ik9 (4.2)0.4250.1631.1070.072 21--40131 (41.9)55 (56.7 )76 (35.2)0.4150.2540.676\<  0.001 41--60116 (37.1)23 (23.7)93 (43.1)2.4331.4184.1740.001  ≥ 6148 (15.3)10 (10.3)38 (17.6)1.8570.8843.9020.098Male226 (72.2)70 (72.2156 (72.2)1.0030.5881.7120.992Admission departments Department of Cardiology89 (28.4)26 (26.8)63 (29.2)1.1240.6571.9230.668 Department of Cardiothoracic Surgery80 (25.6)19 (19.6)61 (28.2)1.6160.9022.8920.105 Department of Infectious Disease47 (15.0)10 (10.3)37 (17.1)1.7980.8553.7840.118 Department of Respiratory24 (7.7)14 (14.4)10 (4.6)0.2880.1230.6740.003 Department of Nephrology16 (5.1)8 (8.2)8 (3.7)0.4280.1561.1760.158Predisposing factors Health care-related21 (6.7)3 (3.1)18 (8.3)2.8480.8199.9090.087 Basic heart disease142 (45.4)47 (48.5)95 (44.0)0.8350.5171.3500.462 Congenital heart disease52 (16.6)20 (20.6)32 (14.8)0.6700.3611.2430.202 Rheumatic heart disease60 (19.2)22 (22.7)38 (17.6)0.7280.4031.3130.290 Degenerative heart valve disease24 (7.7)4 (4.1)20 (9.3)2.3720.7897.1380.114 Intravenous drug users51 (16.3)25 (25.8)26 (12.0)0.3940.2140.7270.002 Prosthetic valve replacement11 (3.5)3 (3.1)8 (3.7)1.2050.3134.6440.952 Pacemaker3 (1.0)1 (1.0)2 (0.9)1.0000.08010.0140.897† Previous IE history8 (2.6)2 (2.1)6 (2.8)1.3570.2396.8480.987 Recent skin infection10 (3.2)3 (3.1)7 (3.2)1.0490.2664.1470.781 Diabetes28 (8.9)5 (5.2)23 (10.6)2.1930.8085.9510.115Age is presented as mean ± standard deviation. Other variables are presented as count (%). *P* value were estimated by \*independent sample t test, Chi-squared tests or †Fisher exact tests. One patient could have two or more underlying predisposing factors

Manifestations and complications {#Sec8}
--------------------------------

Table [2](#Tab2){ref-type="table"} details the manifestations and complications of the 313 IE patients in this study. Our results showed that two groups had similar clinical features, including fever, heart murmurs, hypoproteinemia, anemia, chest pain, heart insufficiency, embolism and hemorrhagic stroke despite radiographically visible splenomegaly (26.4% vs 15.5%, OR = 1.960, CI: 1.046--3.673) and ischemic stroke (27.3% vs 10.3%, OR = 3.269, CI: 1.592--6.714), which was more frequently found in later-period group, while pulmonary embolism (1.9% vs 7.2%, OR = 0.243, CI: 0.069--0.849) and renal failure (6.0% vs 15.5%, OR = 0.350, CI: 0.160--0.768) seemed to appear less often in later-period group. Table 2Manifestations and complications of 313 patientsVariableTotalEarly-period GroupLater-period GroupOR95% CI*PN* = 313*N* = 97*N* = 216LowerUpperManifestations Fever262 (83.7)81 (83.5 )181(83.8)1.0220.5351.9510.949 Cardiac murmurs262 (83.7)87 (89.7)175(81.0)0.4910.2351.0260.055 Splenomegaly72 (23.0)15 (15.5)57 (26.4)1.9601.0463.6730.034 Chest pain38 (12.1)14 (14.4)24(11.1)0.7410.3651.5040.405 Janeway lesion11 (3.5)6 (6.2 )5 (2.3)0.3590.1071.2080.165 Osler nodes5 (1.6 )3 (3.1)2 (0.9)0.2930.0481.7810.354Labotory foundings Leukocytosis or neutrophilia199 (63.6)64 (66.0)135 (62.5)0.8590.5201.4200.554 Anemia247 (78.9)80 (82.5)167 (77.3)0.7240.3921.3360.301 Hypoproteinemia293 (93.6)90 (92.8)203 (94.0 )1.2150.4693.1460.689Comlications Heart insufficiency182 (58.1)60 (61.9)122 (56.5)0.8000.4901.3070.343 Acute congestive heart failure67 (21.4)23 (23.7)44 (20.4)0.8230.4641.4600.505Embolism82 (26.2)19 (19.6)63 ( 29.2 )1.6900.9463.0220.075 Ischemic stroke69 ( 22.0 )10 ( 10.3 )59 ( 27.3 )3.2691.5926.714\<0.001 Pulmonary embolism11 ( 3.5 )7 ( 7.2 )4 ( 1.9 )0.2430.0690.8490.040 Renal infarction7 (2.2)3 (3.1)4 (1.9)0.5910.1302.6940.785 Splenic infarction20 (6.4)4 (4.1)16 (7.4)1.8600.6055.7170.272 Hemorrhagic stroke27 (8.6)7 (7.2)20 (9.3)1.3120.5353.2150.552 Metastatic abscess18 (5.8)6 (6.2)12 ( 5.6 )0.8970.3262.4630.832 Pulmonary abscess14 ( 4.5 )4 ( 4.1 )10 ( 4.6 )1.1290.3453.6920.924 Cerebral abscess7 ( 2.2 )3 ( 3.1 )4 ( 1.9 )0.5910.1302.6940.785 Renal insufficiency28 ( 8.9 )15 ( 15.5 )13 ( 6.0 )0.3500.1600.7680.007 No complications27 ( 8.6 )9 ( 9.3 )18 ( 8.3 )0.8890.3842.0560.783Variables are presented as count (%). *P* value were estimated by Chi-squared tests. One patient could have two or more manifestations and complications

Blood culture {#Sec9}
-------------

All 311 IE patients in our study were subjected to blood culture, while blood culture-negative IE (BCNE) patients accounted for 41.8%. The BCNE rate of the later-period group was lower than that of the earlier group (37.0% vs 52.6%, OR = 0.529, CI: 0.325--0.863). The types of microorganism found in the 181 patients with positive blood culture results are summarized in Table [3](#Tab3){ref-type="table"}. Gram-positive cocci (89.0%) dominated the list, followed by Gram-negative bacilli (6.1%), other bacterial (3.9%) and fungi (3.3%). *Staphylococcus aureus* and Streptococcus were separately the most frequent microorganism in earlier-period group and later-period group. The presence of *Staphylococcus aureus* in the later-period group was less common than in the early-period group (20.0% vs 41.3%, OR = 0.355, CI: 0.172--0.732). Instead, with the exception of *Staphylococcus aureus* and streptococcus, other gram-positive cocci, such as Enterococcus (9.6% vs 2.2%) and *Globicatella Sanguis* (6.7% vs 4.3%)*,* got a notably increase (27.4% vs 13.0%, OR = 2.517, CI: 0.985--6.429) in later-period group. Table 3Microorganism found in the 181 patients with positive blood culture resultsVariableTotalEarly-period GroupLater-period GroupOR95% CI*PN* = 181*N* = 46*N* = 135LowerUpperGram-positive coccus161 (89.0)40 (87.0)121 (89.6)1.2960.4673.5990.617 *Staphylococcus aureus*46 (25.4)19 (41.3)27 (20.0)0.3550.1720.7320.004 Streptococcus76 (42.0)17 (37.0)59 (43.7)1.3240.6652.6360.423 Other43 (23.8)6 (13.0)37 (27.4)2.5170.9856.4290.048 Enterococcus14 (7.7)1 (2.2)13 (9.6)4.7950.61037.7150.188 *Globicatella Sanguis*11 (6.1)2 (4.3)9 (6.7)1.5710.3277.5540.833 Gram-negative bacilli11 (6.1)1 (2.2)10 (7.4)3.6000.44828.9220.355 Other bacterial7 (3.9)2 (4.3)5 (3.7)0.8460.1584.5180.805 Fungi6 (3.3)3 (6.5)3 (2.2)0.3260.0631.6740.352Variables are presented as count (%). P value were estimated by Chi-squared tests. One patient could be isolated two or more kinds of causative microorganisms from blood culture

Echocardiography {#Sec10}
----------------

All patients underwent a transthoracic echocardiography (TTE) examination and 274 (87.5%) showed positive results (Table [4](#Tab4){ref-type="table"}). Only 3 patients of prosthetic valve endocarditis, with negative TTE results, were confirmed by transesophageal echocardiography (TOE). The proportion of negative TTE results was 45.5 and 11.3% respectively for prosthetic valve endocarditis and native valve endocarditis. There were significantly more negative results in the later-period group than in the early-period group (15.3% vs 6.2%, OR = 2.735, CI: 1.106--6.764). We observed that 199 (63.6%) cases were left-sided endocarditis, 60 (19.2%) cases were right-sided endocarditis, 9 (2.9%) cases showed vegetations on both sides of cardiac valve, and 6 cases developed vegetations on non-valvular endocardium. The later-period group presented a lower proportion of right-sided endocarditis compared to the early-period group (16.2% vs 25.8%, OR = 0.557, CI: 0.311--0.996), especially for endocarditis on tricuspid valve (14.8% vs 24.7%, OR = 0.529, CI: 0.292--0.959). Table 4Echocardiography results of 313 patientsVariableTotalEarly-period GroupLater-period GroupOR95% CI*P*N = 313N = 97N = 216LowerUpperVegetation No vegetation39 (12.5)6 (6.2)33 (15.3)2.7351.1066.7640.024 Left cardiac valve199 (63.6)60 (61.9)139 (64.4)1.1130.6781.8270.671 Mitral valve105 (33.5)30 (30.9)75 (34.7)1.1880.7111.9860.511 Aortic valve72 (23.0)23 (23.7)49 (22.7)0.9440.5361.6630.842 Mitral and aortic valve22 (7.0)7 (7.2)15 (6.9)0.9590.3782.4340.931 Right cardiac valve60 (19.2)25 (25.8)35 (16.2)0.5570.3110.9960.047 Tricuspid valve56 (17.9)24 (24.7)32 (14.8)0.5290.2920.9590.034 Pulmonary valve4 (1.3)1 (1.0)3 (1.4)1.3520.13913.1660.777 Both left and right cardiac valve9 (2.9)2 (2.1)7 (3.2)1.5910.3247.8020.833 Peripheral abscess14 (4.5)5 (5.2)9 (4.2)0.8000.2612.4530.924 Severe regurgitation190 (60.7)57 (58.8)133 (61.6)1.1240.6901.8330.638Variables are presented as count (%). *P* value were estimated by Chi-squared tests

Outcomes and predictors of in-hospital mortality {#Sec11}
------------------------------------------------

All patients received antibiotic therapy, with 160 (51.1%) submitted to early surgery. Twenty-seven cases (8.6%) were submitted to late surgical intervention based on their specific condition such as hemodynamic instability, uncontrolled sepsis, shock and organ failure (Table [5](#Tab5){ref-type="table"}). Table 5Treatment regimen and outcomes of 313 IE patientsVariableTotalEarly-period GroupLater-period GroupOR95%CI*P*N = 313N = 97N = 216lowerupperTreatment regimen Antibiotic plus surgery187 (59.7)57 (58.8)130 (60.2)1.0610.6521.7270.812 Early surgery160 (51.1)48 (49.5)112 (51.9)1.0990.6811.7750.698 Late surgery27 (8.6)9 (9.3)18 (8.3)0.8890.3842.0560.783 Death35 (11.2)13 (13.4)22 (10.2)0.7330.3521.5230.404 Acute heart failure14 (4.5)4 (4.1)10 (4.6)1.1290.3453.6920.924 Cerebrovascular events10 (3.2)3 (3.1)7 (3.2)1.0490.2664.1470.781 Septic shock and multiple organ failure9 (2.9)5 (5.2)4 (1.9)0.3470.0911.3220.211 Others2 (0.6)1 (1.0)1 (0.5)0.4470.0287.213†0.524†Variables are presented as count (%). *P* value were estimated by Chi-squared tests or †Fisher exact tests

A total of 35 patients (11.2%) died in hospital, 11 in the early-period group and 24 in the later-period group. Of these, 14 died from acute heart failure, 10 from cerebrovascular events, 9 from septic shock and multiple organ failure, and 1 each from severe arrhythmia and acute myelitis. There was no significant difference in in-hospital mortality between two groups.

Multivariate analysis of the clinical variables found to have statistical significance in the univariate analysis (Table [6](#Tab6){ref-type="table"}) identified the following as independent predictors of in-hospital mortality: intravenous drug addicted (OR = 4.290, CI: 1.098--16.758), prosthetic valve endocarditis (OR = 7.374, CI: 1.177--46.179), hemorrhagic stroke (OR = 5.804, CI: 1.830--18.413), acute congestive heart failure (OR = 10.607, CI: 3.842--29.284), renal insufficiency (OR = 9.268 CI: 2.924--29.382), left-sided endocarditis (OR = 5.606, CI:1.461--21.512), and early surgery (OR = 0.099, CI:0.030--0.330) (Table [7](#Tab7){ref-type="table"}). The goodness-of-fit of the multivariable model was determined by Hosmer--Lemeshow test (Chi-square = 1.562, *P* = 0.955). Table 6Factors associated with in-hospital mortality: univariate analysisFactorCategoryNumberDeathsOR95% CI*P*lowerupperBasic Age\< 4014911(7.38)0.4650.2190.9860.042\> = 4016424(14.63) Sexmale22632(14.16)4.6191.37615.5010.007female873(3.45) Health care-relatedyes217(33.33)4.7141.75612.6540.003no29228(9.59) Intravenous drug usersyes5110(19.61)2.3121.0345.1710.037no26225(9.54)Clinical findings Hemorrhagic strokeyes2710(37.04)6.1412.54114.840\< 0.001no28625(8.74) Embolismyes8215(18.29)2.3621.1454.8700.017no23120(8.66) Ischemic strokeyes6914(20.29)2.7031.2925.6530.007no24421(8.61) Heart insufficiencyyes18227(14.84)2.6781.1756.1030.016no1318(6.11) Acute congestive heart failureyes6721(31.34)7.5653.58615.961\< 0.001no24614(5.69) Renal insufficiencyyes2812(42.86)8.5433.61020.217\< 0.001no28523(8.07) Pneumoniayes14525(17.24)3.2921.5237.1150.002no16810(5.95) Pleural effusionyes13521(15.56)2.1581.0534.4210.033no17814(7.87) Albumin\< 30 g/L14724(16.33)2.7471.2975.8480.007\> 30 g/L16611(6.63)Microorganism Blood culturePositive18125(13.81)1.9550.9054.2250.084Negative13210(7.58) *Staphylococcus aureus*yes469(19.57)2.2550.9805.1880.051no26726(9.74) Fungiyes63(50.00)8.5941.66444.3750.002no30732(10.42)Echocardiography VegetaionNegative390(0.00)1.1461.0961.2000.036Positive18135(19.34) Left heartyes19928(14.07)2.5031.0565.9310.032no1147(6.14) Both left and right heartyes94(44.44)7.0451.79727.6210.007no30431(10.20) Valve typeProsthetic114(36.36)4.9951.38418.0290.027Native30231(10.26) Surgery treatmentyes1879(4.81)0.1940.0880.431\< 0.001no12626(20.63) Early sugeryyes1606(3.75)0.1670.0670.414\< 0.001no15329(18.95)*P* value were estimated by Chi-squared tests or †Fisher exact tests Table 7Multivariate predictors of in-hospital mortalityFactorBOR95% CI*P*lowerupperIntravenous drug users1.4564.2901.09816.7580.036Prosthetic valve endocarditis1.9987.3741.17746.1790.033Hemorrhagic stroke1.7595.8041.83018.4130.003Acute congestive heart failure2.36210.6073.84229.284\< 0.001Renal insufficiency2.2279.2682.92429.382\< 0.001Left-sided endocarditis1.7245.6061.46121.5120.012Early surgery−2.3110.0990.0300.330\< 0.001Constant−13.894\< 0.001The goodness-of-fit of the multivariable model was determined by Hosmer--Lemeshow test (Chi-square = 1.562, *P* = 0.955)

Discussion {#Sec12}
==========

IE is a fatal disease with diversity of clinical manifestations and risk factors, continuing to be associated with high mortality despite of novel diagnostic and therapeutic strategies \[[@CR1]\]. The demographics, predisposing factors, clinical features, and microbiological spectrum of IE have evolved in recent decades. Relative studies remain scarce in China, and are usually of small sample. Our study was aimed to better understand the regional characteristics and the changing profile of IE over 18 years in our hospital, and to evaluate independent factors that influence the outcome of IE. To our knowledge, this is the largest study on IE performed in our region over 18 years.

Clinical features {#Sec13}
-----------------

Many studies detected an increase in cases of IVDU-related IE, a trend that has been documented in Australia \[[@CR15]\], America \[[@CR16]--[@CR18]\] and Sweden \[[@CR19]\]. Conversely, in our study, the proportion of IVDU-related IE declined by half in later-period group as the Chinese government had been stepping up efforts to crack down drug cartels \[[@CR20]\], which might play an important reason for the changing profile of IE for 18 years in our region. IE patients in developed countries \[[@CR8], [@CR21]--[@CR24]\] were markedly older than developing regions \[[@CR10], [@CR24]--[@CR26]\]. The mean age of IE patients in the International Collaboration on Endocarditis--Prospective Cohort Study (ICE-PCS), the largest cohort study of IE worldwide, was 57.9 years old \[[@CR6]\], far older than ours (42.3 years old). As the young are more likely to be exposed to drugs compared to the middle-age and the old \[[@CR17], [@CR27]\], the downward trend of intravenous drugs abusing may be responsible for upward tendency of onset age in the later-period group. It is generally known that IVDU-related IE is more likely to be *Staphylococcus aureus*-related, and usually more frequently occur on tricuspid valve \[[@CR27], [@CR28]\]. With the significantly lower proportion of IVDUs, *Staphylococcus aureus* cultured from blood and vegetations on tricuspid valve decreased strikingly in the later-period group. Meanwhile, the decrease of patients with pulmonary embolism in the later-period group could be explained by less numerous right-sided IE. Besides, the lower occurrence of renal insufficiency in the later-period group might benefit from the reduction in *Staphylococcus aureus,* which was perceived as a risk factors for acute renal failure in some study \[[@CR29]\].

Beyond the IVDU-related IE, there were still some other points below worth mentioning.

IE patients of the later-period group developed less ischemic stroke. Previous studies reported that *Staphylococcus aureus* infection and vegetations on the mitral valve were risk factors for ischemic stroke \[[@CR30], [@CR31]\], but among the patients in this study, the later-period group showed a lower percentage of *Staphylococcus aureus* infection and a nonsignificant rise in patients with mitral vegetations. We speculate that an older age at onset and a higher proportion of diabetics may play a more important role in triggering ischemic stroke.

The ICE-PCS reported that 87.1% of cases had echocardiographic evidence of vegetation \[[@CR6]\], similar to our data. The negative echocardiography results (absence of vegetations) is still a stumbling block to diagnosis, which increased significantly in the later-period group. The most frequent explanations for a negative echocardiogram are very small vegetations, non-oscillating and/or atypically located vegetations, or severe, pre-existing lesions from rheumatic heart disease or degenerative heart disease in heart valves \[[@CR32]\]. For suspected cases or cases with negative TTE, especially when a prosthetic heart valve or an intracardiac device is present, the appliance of TOE is strongly recommended \[[@CR11], [@CR32]\]. However, we observed that TOE was rarely applied to above cases in our study, which exactly need an improvement.

Up to 41.8% of patients were blood-culture negative in our study, which was similar to other region of China (from 31.4 to 51%) \[[@CR10], [@CR26], [@CR33]\]. According to the available literature, the incidence of BCNE has been reported to be 7% in North America \[[@CR6]\], 5.2--24% in Europe \[[@CR9], [@CR24], [@CR34], [@CR35]\], 20% in Japan \[[@CR36]\], 20% in South America \[[@CR6]\], 31--69% in South Asia \[[@CR24], [@CR37], [@CR38]\]. Therefore we could draw a conclusion that BCNE occurs more frequently in developing countries. BCNE is associated with inappropriate antibiotic treatment, faulty culture techniques, atypical pathogens that are difficult to culture or identify \[[@CR39]\]. Among these factors, the misuse and overuse of antibiotics remained a problem, especially for patients with long-term fever. Atypical pathogens can be identified by serological analysis and polymerase chain reaction (PCR) assays of blood and pathological specimens \[[@CR40]\], which is difficult to realize in clinical practice due to economic and subjective factors. With the development of improved microbial culture techniques, increased medical expertise, and more accurate specifications for the diagnostic and treatment processes, the negative blood-culture rate achieved a remarkable decline in the later-period group. Still, there is room for improvement and research efforts need to be continued.

A systematic review of 21 regional literatures in the world revealed that the average fatality rate of IE is 21.1% ± 10.4% \[[@CR2]\], and the ICE-PCS pointed out the in-hospital mortality was 18% worldwide by average \[[@CR6]\]. The in-hospital mortality of our study was 11.2%, nearly approaching to the lower limit and quite similar to another research conducted in East China (10.9%). Moreover, it is noteworthy that even with the novel diagnostic and therapeutic strategies available now, the in-hospital mortality did not strikingly differ between the two groups, which means minimizing the in-hospital mortality of IE is still a long-term undertaking.

Risk factors for in-hospital mortality {#Sec14}
--------------------------------------

To explore the independent risk factors for in-hospital mortality, we performed a forward stepwise logistic regression analysis model. The results indicated that IVDUs, prosthetic valve endocarditis \[[@CR6], [@CR41]\], hemorrhagic stroke, acute congestive heart failure \[[@CR26], [@CR42]--[@CR44]\], renal insufficiency \[[@CR42]\], left-sided endocarditis and early surgical treatment \[[@CR6], [@CR44]--[@CR46]\] were the independent determinants of in-hospital mortality. Among these factors, prosthetic valve endocarditis had the highest odds ratio. Many of them are also confirmed by previous researches. Some factors, such as age, embolism (or Ischemic stroke), health-related endocarditis. Were finally ruled out from forward stepwise method logistic regression analysis model, probably due to the multicollinearity with other variables. In other studies, increasing age, health care-associated IE, *Staphylococcus aureus* related IE, coagulase-negative staphylococcal infection, paravalvular complications and diabetes mellitus \[[@CR6], [@CR8], [@CR47], [@CR48]\] are also important factors contributing to the in-hospital mortality. These discrepancies may due to differences in samples and study design.

Early surgery has been proved to be associated with a significantly lower in-hospital mortality rate as compared to medical therapy \[[@CR49], [@CR50]\] Mortality of patients who underwent surgery was one sixth of that of patients who did not have the surgery. In our study, up to 59.7% of our patients underwent surgery during hospitalization, which is similar to other regions like Brazil (52.4--55.0%) \[[@CR43]\], Spain (57.0%) and France (31.0--71.0%) \[[@CR34]\], but relatively higher compared to Japan (17.0%) \[[@CR8]\] and North America (45.0%). The ICE-PCSS showed that 46% of patients worldwide underwent early surgery \[[@CR46]\]. In our studies, nearly 51.1% of cases were admitted to early surgery, which turned to be the only protective factor for prognosis of IE in our multivariate model. We believe that good standard of care in our hospital, and relatively younger age were a major reason for patients to make aggressive decision of surgical treatment.

The difference of in-hospital mortality between IVDU-related IE and none-IVDU-related IE was reported to be of no significance in previous studies \[[@CR18], [@CR51], [@CR52]\], inconsistent with our conclusion. We speculated that the higher *Staphylococcus aureus* septicemia and repeated infection brought by intravenous drugs busing might contribute to the higher in-hospital mortality. We strongly proposed to conduct more further studies so as to verify our conclusions.

Limitation {#Sec15}
----------

This study focused on a single-center in a general teaching hospital without long-term follow-up. Most patients came from south China, thus findings in this study may not be applicable to all populations. Besides, referral bias should be taken into consideration when describing the clinical spectrum and outcome of IE, as patients with more complications such as stroke, heart failure and new valvular regurgitation and surgery indications, who are more likely to be gravely ill patients, are more likely to choose a tertiary hospital \[[@CR53]\]. So our conclusions may not apply to small hospital. However, our observations reflected a dynamic change of IE in our center over a period of eighteen consecutive years with a relatively large sample size, while relative study remains scarce in China. The geographic variations observed in our study will be of important value to profile the clinical feature of China and offer the reference for clinical decisions in our region.

Conclusion {#Sec16}
==========

In conclusion, intravenous drug abuse was less common in later-period group, which might result in a series of changes like older age of onset, fewer pulmonary embolism, renal failure, *Staphylococcus aureus* endocarditis and right-sided IE. More ischemic stroke was observed possibly due to older age. Also, patience in later-period showed more splenomegaly, lower BCNE rate and negative echocardiography results. The in-hospital mortality stayed still despite of the changing profile of IE. The multivariate analysis underlined the significance of prosthetic valve endocarditis, intravenous drug addicted, hemorrhagic stroke, congestive heart failure, renal insufficiency, left-sided endocarditis, fungal endocarditis and surgical treatment to in-hospital mortality.

BC

:   Blood culture

CI

:   Confidence interval

CT

:   Computed Tomography

ESC

:   European Society of Cardiology.

FDG

:   Fluorodeoxyglucose

IE

:   Infective endocarditis

IVDU

:   Intravenous drug users

NCBC

:   Blood culture-negative infective endocarditis

OR

:   Odds ratio

PCR

:   Polymerase chain reaction

TTE

:   Transthoracic echocardiography
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